| |
|
|
- MEK Inhibitor Binimetinib
- Binimetinib, also known as MEK162, ARRY-162 or ARRY-438162, is a selective and oral MKE inhibitor. Binimetinib is used to treat various cancers as an anti-cancer small molecule and is a central kinase in the tumor-promoting MAPK pathway.
-
MedChemHub
[Verified]
|
|
Negotiable
|
